Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 8/1/1991


1.		A Phase I/II Clinical Trial of Brequinar plus Fluorouracil in Patients with Refractory Solid Tumors (Summary Last Modified 08/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 80								YALE-HIC-5506 NCI-V91-0051

Last Modified: 6/1/1989


2.		Phase II Chemotherapy with DuP-785 in Patients with Adenocarcinoma of the Pancreas (Summary Last Modified 06/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 75								EORTC-16871P

Last Modified: 3/1/1989


3.		Phase II Chemotherapy with DuP-785 in Patients with Advanced Breast Cancer (Summary Last Modified 03/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 74								EORTC-16871B

Last Modified: 3/1/1989


4.		Phase II Chemotherapy with DuP-785 in Patients with Advanced Colorectal Cancer (Summary Last Modified 03/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				19 to 74								EORTC-16871C

Last Modified: 4/26/2007


5.		Phase II Chemotherapy with DuP-785 in Patients with Advanced Renal Adenocarcinoma (Summary Last Modified 03/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 75								EORTC-16871K

Last Modified: 3/1/1989


6.		Phase II Chemotherapy with DuP-785 in Patients with Advanced Malignant Melanoma (Summary Last Modified 03/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 75								EORTC-16871M

Last Modified: 4/1/1989


7.		Phase II Chemotherapy with Brequinar Sodium (DuP 785) Administered on a Once-Weekly Schedule in Patients with Refractory Solid Tumors (Summary Last Modified 04/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 80								UNM-2088C NCI-V89-0021

Last Modified: 5/1/1990


8.		Phase II Chemotherapy with Brequinar Sodium (DuP 785) Administered on a Once-Weekly Schedule in Patients with Advanced Solid Tumors (Summary Last Modified 05/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 80								YALE-HIC-5218 NCI-V89-0234

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute